Medindia

X

The Majority of Surveyed Clinicians Who Have Prescribed Nucynta for Inflammatory and Nociceptive Pain Perceive the Drug to Have Efficacy That is Comparable to Oxycodone

Monday, May 24, 2010 General News J E 4
Advertisement
However, Nucynta and Embeda - Which Both Launched in 2009 - Are Still Excluded From Many Commercial and Medicare Drug Plans, According to a New Report from Decision Resources

For more information, contact:

Decision Resources, Inc.

Christopher Comfort

781-296-2597

ccomfort@dresources.com

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
AdvanDx to Offer BinaxNOW® PBP2a Test for Rapid De...
S
Dr. Ershadi Reveals the Benefits of Natural Remedi...